CPRX Financial Facts

Loss from operations: -3.25M
Total operating costs and expenses: 3.25M
See Full Income Statement

Cash and cash equivalents: 2.22M
Accounts payable: 850.79K
See Full Balance Sheet

Catalyst Pharmaceutical Partners Inc. (CPRX) Earnings

  |   Expand Research on CPRX
Next EPS Date 5/19/14 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +53.6% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +8.2% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
3/19/14 Q413 $0.00-$0.07 +$0.07N/AN/A N/A -5.5% Details
11/14/13 Q313 -$0.07-$0.07 $0.00N/AN/A N/A +56.1% Details
8/15/13 Q213 -$0.06-$0.07 +$0.01N/AN/A N/A +42.1% Details
5/16/13 Q113 $0.00-$0.08 +$0.08N/AN/A N/A 0% Details
4/2/13 Q412 $0.00-$0.09 +$0.09N/AN/A N/A 0% Details
11/15/12 Q312 -$0.08N/A N/A N/AN/A N/A 0% Details
8/15/12 Q212 -$0.01-$0.05 +$0.04N/AN/A N/A +30.4% Details
5/16/12 Q112 -$0.04-$0.08 +$0.04N/AN/A N/A 0% Details